Skip to content

A real-world study on the rationalization of patient-controlled intravenous analgesia after general anesthesia surgery

A real-world study on the rationalization of patient-controlled intravenous analgesia after general anesthesia surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098028
Enrollment
Unknown
Registered
2025-02-28
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients requiring a patient-controlled analgesia pump after general anesthesia surgery

Interventions

Nalbuphine:None
Nalbuphine combined with sufentanil:None

Sponsors

The Third People's Hospital of Hubei Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years old, who are scheduled to undergo PCIA after general anesthesia surgery; Can understand the process and methods of this study, voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients who have adopted other methods of pain relief or used multiple pain control approaches; 2.Patients with a history of allergies or who are allergic to anesthetic drugs; 3.Patients with language communication disorders or those who are unable to communicate; 4.Patients deemed unsuitable for participation by the researchers;

Design outcomes

Primary

MeasureTime frame
VAS pain score (resting and active);

Secondary

MeasureTime frame
Number of PCA compressions;Medication for salvage analgesia and number of times of salvage analgesia (T2);Incidence of adverse reactions;

Countries

China

Contacts

Public ContactShu Rong

The Third People's Hospital of Hubei Province

1154586369@qq.com+86 136 5728 6028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026